IBRX possibly working its way to an epic short squeeze?

Pressure will start to build around 3.70-3.80.

Fintel reporting short interest around 37% with 8 days to cover this thing may actually blow. World renowned doctor Dr. Pat Soon-Shiong announced a few days ago that they have some major announcements this week, followed by Saudi FDA granting approval to their ANKTIVA + checkpoint inhibitor the first approved chemotherapy-free immunotherapy that activates both natural killer cells and killer T cells, heralding the era of immunotherapy 2.0. This thing has the catalyst it needs, the metrics, and the volume.

This is not financial advice. DYOR